IBA SA : IBA signs new contract with the University of Florida Health Proton Therapy Institute
08 Avril 2016 - 7:00AM
IBA signs new contract with the University of
Florida Health Proton Therapy Institute
Contract worth approximately $30 million includes
a new Proteus®One system and current equipment upgrades
Louvain-la-Neuve, Belgium, April
8, 2016 - IBA (Ion Beam Applications
S.A.), the world's leading provider of proton therapy solutions for
the treatment of cancer, announces that it has signed a contract
with the University of Florida Health Proton Therapy Institute
(UFHPTI) to install a new Proteus®One* system
and to upgrade its current proton therapy equipment with IBA's
latest technologies.
IBA will equip UFHPTI with its
compact Proteus®One system,
which includes its next-generation precision technologies of Pencil
Beam Scanning (PBS) and Cone Beam CT (CBCT) capabilities as well as
the Philips Ambient Experience. The current proton therapy center,
which has treated more than 6,000 patients with IBA technology
since 2006, will also be upgraded with the latest in IBA
technologies, including PBS, CBCT as well as AdaPT
Insight, IBA's platform for adaptive proton therapy and
patient-centric workflow.
The contract also includes an
operation and maintenance agreement for the Proteus®One system. In
total, the contract is worth approximately $30 million to IBA. The
UFHPTI expansion and addition of the Proteus®One
system is estimated for completion in 2018. The installation of new
PBS and CBCT technologies in the existing proton therapy system
will start once the new Proteus®One system is
installed.
Olivier Legrain,
Chief Executive Officer of IBA, commented: "We are delighted
that UFHPTI, one of the early pioneers in proton therapy, has
chosen IBA for its expansion by adding our compact
Proteus®One system and
upgrading its current system. IBA's commitment to customers is to
ensure that all of our users are able to upgrade to the most
advanced technology over the lifetime of the equipment, without
disruption to patient treatment. We look forward to continuing
our collaboration with UFHPTI as we work together to advance
the use of proton therapy in the fight
against cancer."
Nancy Mendenhall,
MD, Medical Director of UF Health Proton Therapy
Institute said; "The professional support
and responsiveness that IBA has demonstrated throughout our 10
years has resulted in the successful treatment of many patients
with proton therapy. We are pleased to be able to expand our
clinical service with the addition of the Proteus®One
system which will enable even more patients to benefit from
cutting-edge proton therapy."
***end***
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology
company focused on bringing integrated and innovative solutions for
the diagnosis and treatment of cancer. The Company is the worldwide
technology leader in the field of proton therapy, the most advanced
form of radiation therapy available today. IBA's proton therapy
solutions are flexible and adaptable, allowing customers to choose
from universal full scale proton therapy centers as well as
compact, single room systems. In addition, IBA also has a
radiation dosimetry business and develops particle accelerators for
the medical world and industry.
Headquartered in Belgium and employing about 1,200 people
worldwide, IBA has installed systems across the world, from Europe
and the US and to the emerging markets. IBA is listed on the
pan-European stock exchange EURONEXT. (IBA: Reuters IBAB.BR and
Bloomberg IBAB.BB) and more information can be found at:
www.iba-worldwide.com
*Proteus®ONE is the
brand name of a new configuration of the Proteus®
235
About UF Health Proton Therapy
Institute
UF Health Proton Therapy Institute is a nonprofit 501(c)3
organization affiliated with the UF College of Medicine and the UF
Health Cancer Center, a Florida Cancer Center of Excellence,
dedicated to delivering state-of-the-art cancer treatment and
setting new standards for treating and curing cancer. It is an
accredited radiation oncology facility by the American College of
Radiology. The cancer treatment facility houses both conventional
radiation and proton therapy, and delivers proton therapy to 100
patients a day. For more information about the UF Health Proton
Therapy Institute, please visit www.floridaproton.org, or call
toll-free 877-686-6009.
For further information please
contact:
IBA
Jean-Marc Bothy
Chief Financial Officer
+32 10 475 890
Investorrelations@iba-group.com
Thomas Ralet
Vice-President Corporate Communication
+32 10 475 890
Communication@iba-group.com |
For media and investor
enquiries:
Consilium Strategic Communications
Amber Fennell, Matthew Neal, Ivar Milligan
+44 (0) 20 3709 5700
IBA@consilium-comms.com
Rx Communications Group (US)
Melody Carey
+ 1 917 322 2571
mcarey@RxIR.com |
PR_IBA_UFPTI_ProteusONE-EN-04.08.2016
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: IBA SA via Globenewswire
HUG#2001789
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024